Have a personal or library account? Click to login
Modulation of microglial function by the antidepressant drug venlafaxine 28 November 2014 Cover

Modulation of microglial function by the antidepressant drug venlafaxine 28 November 2014

Open Access
|Mar 2015

References

  1. Alboni S, Cervia D, Sugama S and Conti B. (2010). Interleukin 18 in the CNS. J Neuroinfl ammation 7: 9-19.
  2. Brummelte S, Lieblich SE and Galea LAM. (2012). Gestational and postpartum corticosterone exposure to the dam aff ects behavioral and endocrine outcome of the off spring in a sexually-dimorphic manner. Neuropharmacol 62: 406-418.
  3. Brunk UT and Terman A. (2002). The mitochondrial-lysosomal axis theory of aging. Eur J Biochem 269: 1996-2002.
  4. Chang Y,Lee JJ, Hsieh CJ, Hsiao G, Chou DS and Sheu JR. (2009). Inhibitory Eff ects of Ketamine on Lipopolysaccharide-Induced Microglial Activation. Mediators Infl amm ID 705379.10.1155/2009/705379266252519343193
  5. Corona AW, Huang Y, O’Connor JS, Dantzer R, Kelley KW, Popovich PG and Godbout JP. (2010). Fractalkine receptor (CX3CR1) defi ciency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation 7: 93.
  6. Crack PJ and Bray PJ. (2007). Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 85: 476-480.
  7. Cuadros MA and Navascues J. (1998). The origin and diff erentiation of microglial cells during development. Prog Neurobiol 56: 173-189.
  8. Daniel WA, Wojcikowski J and Pałucha A. (2001). Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134: 807-814.
  9. Dello Russo C, Boullerne AI, Gavrilyuk V and Feinstein DL. (2004). Inhibition of microglial infl ammatory responses by norepinephrine: eff ects on nitric oxide and interleukin-1β production. J Neuroinfl ammation 1: 9.
  10. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK and Lanctot KL. (2010). A meta-analysis of cytokines in major depression. Biol. Psychiatry 67: 446-457.
  11. Dunn AJ, Wang J and Ando T. (1999). Eff ects of cytokines on cerebral neurotransmission: Comparison with the eff ects of stress. Adv Exp Med Biol 461: 117-127.
  12. Eren I, Nazıroğlu M, Demirdaş A, Celik O, Uğuz AC, Altunbaşak A, Ozmen I and Uz E. (2007). Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat. Neurochem Res 32: 497-505.
  13. Garate I, Garcia-Bueno B, Madrigal JL, Caso CR, Alou L, Gomez-Lus ML, Mico CA, Leza JC. (2013). Stress-Induced Neuroinfl ammation: Role of the Toll- Like Receptor-4 Pathway. Biol Psychiatry 73: 32-43.
  14. Garate I, Garcia-Bueno B, Madrigal JLM, Bravo L, Berrocoso E, Caso JR, Mico JA and Leza JC. (2011) Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 8: 151.10.1186/1742-2094-8-151321957122053929
  15. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T and Yirmiya R.(2008). Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 13: 717-728.
  16. Hamidi M, Drevets WC and Price JL. (2004) Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 55: 563-569.10.1016/j.biopsych.2003.11.00615013824
  17. Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL and Kanba S. (2007). Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp Neurol 206: 33-42.
  18. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF and Godbout JP. (2008). Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinfl ammation, sickness behavior, and anhedonia. J Neuroinflammation 5: 15.
  19. Hinwood M, Morandini J, Day TA and Walker FR. (2012). Evidence that microglia mediate the neurobiological eff ects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 22: 1442-1454.
  20. Horikawa H, Kato TA, Mizoguchi Y, Monji A, Seki Y, Ohkuri T, Gotoh L, Yonaha M, Ueda T, Hashioka S and Kanba S. (2010). Inhibitory eff ects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry 34: 1306-1316.
  21. Howren MB, Lamkin DM and Suls J. (2009). Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med 71: 171-186.
  22. Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, Maier SF and Yirmiya R. (2014). Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry 19: 699-709.
  23. Lanquillon S, Krieg JC, Bening-Abu-Shach U and Vedde H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacol 22: 370-379.
  24. Levine J, Barak Y, Chengapp KNR, Rapoport A, Rebey M and Barak V. (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40: 171-176.10.1159/00002661510559698
  25. Liu B, Wang K, Gao HM, Mandavilli B, Wang JY and Hong JS. (2001). Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 77: 182-189.
  26. Maes M, Kubera M, Obuchowiczwa E, Goehler L and Brzeszcz J. (2011). Depression’s multiple comorbidities explained by (neuro)infl ammatory and oxidative & nitrosative stress pathways. Neuroendocrinol Lett 32: 7-24.
  27. Maletic V, Robinson M, Oakes T, Lyengar S, Ball SG and Russell J. (2007). Neurobiology of depression: an integrated view of key fi ndings. Int J Clin Pract 61: 2030-2040.
  28. Massart R, Mongeau R and Lanfumey L. (2012). Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci 367: 1601.
  29. Michel TM, Pulschen D and Thome J.(2012). The role of oxidative stress in depressive disorders. Curr Pharm Des 18: 5890-9.
  30. Miller AH, Maletic V and Raison CL. (2009). Infl ammation and Its Discontents: The Role of Cytokines in the pathophysiology of Major Depression. Biol Psychiatry 65: 732-741.
  31. Moylan S, Berk M, Dean OM, Samuni Y, Williams L, O’Neil A, Hayley AC, Pasco JA, Anderson G, Jacka F and Maes M. ( 2014). Oxidative & nitrosative stress in depression: Why so much stress? Neurosci Biobehav Rev [in press].10.1016/j.neubiorev.2014.05.00724858007
  32. Muijsers RBR, Van Den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS and Nijkamp FP. (2000). Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol 130: 932-936.
  33. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, Hen R, Koester S, Lederhendler I, Meaney M, Robbins T, Winsky L and Zalcman S. (2002). Preclinical models: status of basic research in depression. Biol. Psychiatry 52: 503-528.
  34. Obuchowicz E, Bielecka AM, Paul-Samojedny M, Pudełko A and Kowalski J.(2014). Imipramine and fl uoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacol Rep 66: 34-43.
  35. Obuchowicz E, Kowalski J, Labuzek K, Krysiak R, Pendzich J and Herman ZS.(2006). Amitriptyline and nortriptyline inhibit interleukin-1β and tumour necrosis factor-α release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol 9: 27-35.
  36. Palta P, Samuel LJ, Miller ER and Szanton SL. (2014). Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 76: 12-19.
  37. Pan Y, Chen XY, Zhang QY and Kong LD. (2014). Microglial NLRP3 infl ammasome activation mediates IL-1β-related infl ammation in prefrontal cortex of depressive rats. Brain Behav Immun 41: 90-100.
  38. Raison CL, Capuron L and Miller AH.(2006). Cytokines sing the blues: infl ammation and the pathogenesis of depression. Trends Immunol 27: 24-31.
  39. Schildkraut JJ. (1965). The catecholamine hypothesis of aff ective disorders: a review of supporting evidence. Am J Psychiatry 122: 509- 522.
  40. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG and Bogerts B. (2008) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42: 151-157.10.1016/j.jpsychires.2006.10.01317174336
  41. Suarez EC, Lewis JG and Kuhn C. (2002). The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men. Brain Behav Immun 6: 675-684.
  42. Suarez EC, Lewis JG, Krishnan RR and Young KH. (2004). Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinol 29: 1119-1128.
  43. Thomas WE. (1999). Brain macrophages: on the role of pericytes and perivascular cells. Brain Res Rev 31: 42-57.
  44. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA and Walker FR. (2012). A comparative examination of the anti-infl ammatory eff ects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26: 469-479.
  45. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuff er W and Fassbender K. (2007). Role of the toll-like receptor 4 in neuroinfl ammation in Alzheimer‘s disease. Cell Physiol Biochem 20: 947-56.
  46. Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner M, Bailey MT, Nelson RJ, Godbout JP and Sherida JF. (2011). β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat. J Neurosci 31: 6277-6288.
  47. Young JJ, Bruno D and Pomara N. (2014). A review of the relationship between proinfl ammatory cytokines and major depressive disorder. J Aff ect Disord 169: 15-20.
  48. Zhou QG, Zhu LJ, Chen C, Wu HY, Luo CX, Chang L and Zhu DY. (2011). Hippocampal Neuronal Nitric Oxide Synthase Mediates the Stress-Related Depressive Behaviors of Glucocorticoids by Downregulating Glucocorticoid Receptor. J Neuroscience 31: 7579-7590.
DOI: https://doi.org/10.2478/intox-2014-0029 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 201 - 207
Submitted on: Nov 2, 2014
|
Accepted on: Nov 29, 2014
|
Published on: Mar 4, 2015
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Michal Dubovický, Eszter Császár, Kristína Melicherčíková, Marcela Kuniaková, Lucia Račková, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.